InvestSMART

Nanosonics Limited (ASX: NAN) - Announcements

Current share price for NAN : $2.950 0.04 (1.34%)+

ASX company news and announcements for Nanosonics Limited (NAN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nanosonics Limited (NAN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nanosonics Limited (NAN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nanosonics Limited (NAN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$883 Becoming a substantial holder 22 May 2015 8:27AM $1.890 $2.950 risen by 56.08%
$883 Trophon EPR only proven system to kill cancer causing HPV 18 May 2015 8:49AM $1.580 $2.950 risen by 86.71%
$883 Appendix 4C - quarterly 28 Apr 2015 12:04PM $1.645 $2.950 risen by 79.33%
$883 S&P DJ Indices Announces March Quarterly Review 6 Mar 2015 8:44AM $1.780 $2.950 risen by 65.73%
$883 Placement and Appendix 3B 5 Mar 2015 9:40AM $1.780 $2.950 risen by 65.73%
$883 Trading Halt 3 Mar 2015 9:54AM $1.780 $2.950 risen by 65.73%
$883 Half Year Accounts 18 Feb 2015 8:30AM $1.730 $2.950 risen by 70.52%
$883 Response to Price Query Letter 17 Feb 2015 9:35AM $1.770 $2.950 risen by 66.67%
$883 Nanosonics launches direct operations in North America 6 Feb 2015 8:27AM $1.485 $2.950 risen by 98.65%
$883 Appendix 4C - quarterly 30 Jan 2015 8:31AM $1.350 $2.950 risen by 118.52%
$883 Nanosonics expanding European presence 6 Nov 2014 8:42AM $0.940 $2.950 risen by 213.83%
$883 New NHS Wales guidelines released 29 Oct 2014 10:32AM $0.950 $2.950 risen by 210.53%
$883 EU study - trophon significantly more effective than wipes 17 Sep 2014 8:53AM $1.090 $2.950 risen by 170.64%
$883 Price Query and Response 2 Sep 2014 8:28AM $1.000 $2.950 risen by 195%
$883 Nanosonics announces trophon EPR approval in Japan 7 Aug 2014 11:36AM $0.820 $2.950 risen by 259.76%
$883 Appendix 4C - quarterly 29 Jul 2014 9:06AM $0.820 $2.950 risen by 259.76%
$883 Trophon EPR included in new AIUM guidelines 19 May 2014 11:04AM $0.800 $2.950 risen by 268.75%
$883 Appendix 4C - quarterly 29 Apr 2014 8:28AM $0.850 $2.950 risen by 247.06%
$883 Nanosonics signs Strategic Partnership with Miele 28 Mar 2014 8:53AM $0.855 $2.950 risen by 245.03%
$883 Half Year Accounts 24 Feb 2014 8:28AM $0.810 $2.950 risen by 264.20%
$883 Appendix 4C - quarterly 31 Jan 2014 9:13AM $0.880 $2.950 risen by 235.23%
$883 Appendix 4C - quarterly 18 Oct 2013 10:51AM $0.900 $2.950 risen by 227.78%
$883 Study highlights risks of conventional disinfection methods 10 Oct 2013 1:28PM $0.760 $2.950 risen by 288.16%
$883 South Korean regulator approves trophon EPR 30 Aug 2013 8:25AM $0.895 $2.950 risen by 229.61%
$883 New executive appointments for M Kavanagh and R Weinberger 28 Aug 2013 10:32AM $0.885 $2.950 risen by 233.33%

726 - 750 of 825 results

Page 30 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.